[go: up one dir, main page]

DK0912517T3 - Fremgangsmåde til fremstilling af phosphodiesterase IV-inhibitorer - Google Patents

Fremgangsmåde til fremstilling af phosphodiesterase IV-inhibitorer

Info

Publication number
DK0912517T3
DK0912517T3 DK97922629T DK97922629T DK0912517T3 DK 0912517 T3 DK0912517 T3 DK 0912517T3 DK 97922629 T DK97922629 T DK 97922629T DK 97922629 T DK97922629 T DK 97922629T DK 0912517 T3 DK0912517 T3 DK 0912517T3
Authority
DK
Denmark
Prior art keywords
phosphodiesterase
inhibitors
preparation
Prior art date
Application number
DK97922629T
Other languages
English (en)
Inventor
Woo-Baeg Choi
Hywyn R D Churchill
Joseph E Lynch
Paul J Reider
Ralph P Volante
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614329.2A external-priority patent/GB9614329D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK0912517T3 publication Critical patent/DK0912517T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97922629T 1996-05-08 1997-05-05 Fremgangsmåde til fremstilling af phosphodiesterase IV-inhibitorer DK0912517T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1683996P 1996-05-08 1996-05-08
GBGB9614329.2A GB9614329D0 (en) 1996-07-08 1996-07-08 Method of preparing phosphodiesterase IV
PCT/US1997/007457 WO1997042172A1 (en) 1996-05-08 1997-05-05 Method of preparing phosphodiesterase iv inhibitors

Publications (1)

Publication Number Publication Date
DK0912517T3 true DK0912517T3 (da) 2000-11-20

Family

ID=26309666

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97922629T DK0912517T3 (da) 1996-05-08 1997-05-05 Fremgangsmåde til fremstilling af phosphodiesterase IV-inhibitorer

Country Status (13)

Country Link
EP (1) EP0912517B1 (da)
JP (1) JP2000510120A (da)
AR (1) AR007041A1 (da)
AT (1) ATE197148T1 (da)
AU (1) AU707289B2 (da)
CA (1) CA2253279A1 (da)
DE (1) DE69703388T2 (da)
DK (1) DK0912517T3 (da)
ES (1) ES2151728T3 (da)
GR (1) GR3034674T3 (da)
PT (1) PT912517E (da)
TW (1) TW418192B (da)
WO (1) WO1997042172A1 (da)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW263495B (da) * 1992-12-23 1995-11-21 Celltech Ltd
GB9326173D0 (en) * 1993-12-22 1994-02-23 Celltech Ltd Chemical compounds and process

Also Published As

Publication number Publication date
TW418192B (en) 2001-01-11
AU2825297A (en) 1997-11-26
AU707289B2 (en) 1999-07-08
ATE197148T1 (de) 2000-11-15
EP0912517A1 (en) 1999-05-06
GR3034674T3 (en) 2001-01-31
WO1997042172A1 (en) 1997-11-13
PT912517E (pt) 2001-03-30
AR007041A1 (es) 1999-10-13
ES2151728T3 (es) 2001-01-01
CA2253279A1 (en) 1997-11-13
JP2000510120A (ja) 2000-08-08
EP0912517B1 (en) 2000-10-25
DE69703388D1 (de) 2000-11-30
DE69703388T2 (de) 2001-05-17

Similar Documents

Publication Publication Date Title
DK0857784T3 (da) Fremgangsmåde til fremstilling af L-lysin
DK0854189T3 (da) Fremgangsmåde til fremstilling af L-lysin
DK0812845T3 (da) Fremgangsmåde til fremstilling af sildenafil
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
DK0824631T3 (da) Fremgangsmåde til inhibering af tilstopning af ledninger med gashydrater
DK1038008T3 (da) Fremgangsmåde til fremstilling af EGIII-lignende enzymer
DK1005517T3 (da) Fremgangsmåde til fremstilling af diglycerider
DK0807086T3 (da) Fremgangsmåde til fremstilling af hydrotalciter
DK0754756T3 (da) Fremgangsmåde til fremstilling af L-lysin
DK1032565T3 (da) Fremgangsmåde til fremstilling af derivater af taxoid-klassen
DK0925285T3 (da) Fremgangsmåde til fremstilling af pyrimidinforbindelser
DK0937068T3 (da) Fremgangsmåde til krystallisation af losartan
DK0831098T3 (da) Mellemprodukter og fremgangsmåde til fremstilling af olanzapin
DK0770687T3 (da) Fremgangsmåde til fremstilling af nicotinsyreamid
DK0966444T3 (da) Fremgangsmåde til fremstilling af pyrazolderivater
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK0756597T3 (da) Fremgangsmåde til fremstilling af puriner
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
DK1027315T3 (da) Fremgangsmåde til fremstilling af n-butanol
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK0946531T3 (da) Fremgangsmåde til fremstilling af thiazol-derivater
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK0975594T3 (da) Fremgangsmåde til fremstilling af indolderivater
DK0927766T3 (da) Enzymatisk fremgangsmåde til fremstilling af (S)-cyanhydriner
DK0951561T3 (da) Enzymatiske fremgangsmåder til fremstilling af (S)-cyanhydriner